Page last updated: 2024-10-27

fleroxacin and Liver Dysfunction

fleroxacin has been researched along with Liver Dysfunction in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Research Excerpts

ExcerptRelevanceReference
"Fleroxacin is a new broad-spectrum quinolone which can be given by the oral route."1.29Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients. ( Cerruti, F; Herrmann, M; Hirschel, B; Leemann, T; Lew, DP; Portmann, R; Schrenzel, J; Weidekamm, E, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schrenzel, J1
Cerruti, F1
Herrmann, M1
Leemann, T1
Weidekamm, E1
Portmann, R1
Hirschel, B1
Lew, DP1

Other Studies

1 other study available for fleroxacin and Liver Dysfunction

ArticleYear
Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6

    Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Bacteremia; Female; Fleroxacin; H

1994